The Histamine H3 Receptor as a Therapeutic Drug Target for Metabolic Disorders: Status, Challenges and Opportunities

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|12|1430-1446

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.12, 2011-06, pp. : 1430-1446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-01 ,pp. : 303-313

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H4 Receptor: A Novel Therapeutic Target for Immune and Allergic Responses

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-12 ,pp. : 1293-1308

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of histamine H 3 receptor agonists and antagonists

By Leurs R.   Blandina P.   Tedford C.   Timmerman H.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 5, 1998-05 ,pp. : 177-184

Elsevier

Access to resources Recommend Favorite

Application of genomics to drug design: the example of the histamine H 3 receptor

By Schwartz J.-C.   Morisset S.   Rouleau A.   Tardivel-Lacombe J.   Gbahou F.   Ligneau X.   Heron A.   Sasse A.   Stark H.   Schunack W.   Ganellin R.C.   Arrang J.-M.  

European Neuropsychopharmacology, Vol. 11, Iss. 6, 2001-12 ,pp. : 441-448

Elsevier

Access to resources Recommend Favorite

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 25-43

Bentham Science Publishers

Access to resources Recommend Favorite